Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-02-05

Clinical Trial Update: Mirtazapine for Treatment of Cancer Associated Anorexia-cachexia [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 trial assessing mirtazapine for cancer-associated anorexia-cachexia in advanced cancer patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • mirtazapine (mirtazapine)

Snippet

Sponsor: Catherine Naseef Hunter | Conditions: Advanced Cancer, Cancer Associated Anorexia - Cachexia | Phase 2, Phase 3 | Status: COMPLETED